VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,070 | -59.1% | 1,000 | -40.1% | 0.00% | – |
| Q2 2023 | $27,054 | +62.5% | 1,669 | +66.9% | 0.00% | – |
| Q1 2023 | $16,650 | +77.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,400 | +213.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | -66.7% | 1,000 | -66.4% | 0.00% | – |
| Q2 2022 | $9,000 | +200.0% | 2,978 | +197.8% | 0.00% | – |
| Q1 2022 | $3,000 | -40.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -61.5% | 1,000 | -50.0% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | +33.3% | 2,000 | +33.3% | 0.00% | – |
| Q1 2021 | $9,000 | +50.0% | 1,500 | +50.0% | 0.00% | – |
| Q4 2020 | $6,000 | -81.2% | 1,000 | -81.8% | 0.00% | – |
| Q3 2020 | $32,000 | +357.1% | 5,500 | +450.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -58.3% | 1,000 | -35.5% | 0.00% | – |
| Q4 2019 | $12,000 | +9.1% | 1,550 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -15.4% | 1,550 | 0.0% | 0.00% | – |
| Q2 2019 | $13,000 | -13.3% | 1,550 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +650.0% | 1,550 | +416.7% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |